John Kopchick, PhD
Goll-Ohio Eminent Scholar, Professor of Molecular Biology
Member Type: Investigator
My research focuses on:
Use of a proteomic platform to identify new biomarkers of pre-diabetes, aging, GH doping, and white adipose depot physiology
Use of a Growth Hormone receptor antagonist to ascertain Growth Hormone's anti-insulin (diabetogenic) action
Function of the Growth Hormone Receptor in liver, adipose, and muscle tissue as it relates to insulin resistance and aging
Function of Growth Hormone Binding Protein as it relates to GH's diabetogenic activity.
For more publication please link to PubMed.
Feb., 2013 Elected to the National Academy of Inventors Chartered Fellows
Dec., 2012 Ohio University Distinguished Professorship
Oct., 2012 Elected President of the Growth Hormone Research Society, Munich,
Apr., 2012 Ohio Patent Impact Award
Apr., 2011 British Endocrine Society Transatlantic Medal, Birmingham, England
Aug., 2010 Philips Medal, Heritage College of Osteopathic Medicine, Ohio University,
May, 2008 Commencement Address, Graduation Ceremony, Indiana University of
Pennsylvania, Indiana, Pa.
May, 2008 Honorary Doctor of Science Degree, Indiana University of Pennsylvania,
Sep., 2007 New York College of Osteopathic Medicine's Riland Award. The Riland
Medal is awarded to individuals who have made outstanding contributions
to medical science and education, health policy, public policy.
Apr., 2007 AMVETS Silver Helmet Award. Highest award given by the AMVETS for
service to the USA.
Jan., 2007 Elected to Growth Hormone Society Research Council
Nov., 2006 Distinguished Alumnus Award, The Graduate School of Biomedical Sciences,
University of Texas, Houston, Texas
Dec., 2002 Distinguished Alumnus Award 2002, The University of Texas M.D. Anderson
Cancer Center, Houston, Texas
1987-Present The Milton and Lawrence H. Goll Eminent Scholar Endowed Professorship
in Molecular and Cellular Biology, Ohio University, Athens, OH